A recent study in an animal model provides direct evidence for the role of the vagus nerve in gut microbiome-brain ...

The distinct population of endothelial cells that line blood vessels in the insulin-producing "islets" of the human pancreas ...

Scientists uncover an enzyme that boosts cancer cell metabolism to fuel growth. The enzyme, GUK1, supports metabolism in cancer cells to help tumors grow.

Targeting mitochondrial retrograde signaling may therefore be promising in the treatment or prevention of metabolic disorders ...

New research explores the wide world of the positives, and potential drawbacks, of new obesity medications. And each brings a new consideration for physicians.

Nelson Aguilar is an LA-based tech how-to writer and graduate of UCLA. With more than a decade of experience, he covers Apple and Google and writes on iPhone and Android features, privacy and ...

New research on nematodes reveals how glial cells maintain and monitor neuronal dendrites. Neurons may get all the glory, but they would be nothing without glial cells. While brain cells do the heavy ...

The disordered gut microflora enters the gut tissue through the impaired gut barrier, activating the nucleotide oligomerization domain (NOD)-like receptors (NLRs) signaling pathway of macrophages ...

ways these pathways affect every aspect of our health. As a result, semaglutide and its fellow glucagon-like peptide-1 drugs are spawning a tremendous outpouring of research that often clarifies ...

and fibrosis to promote the development of MASLD via regulation of Hippo-YAP1/TAZ pathway (Figure 1). The drugs targeting Hippo-YAP1/TAZ signaling might be used to treat MASLD in the future. However, ...

Want to apply for Canada PR? The country is set to introduce four new permanent residency (PR) pathways in 2025, even as the government plans to reduce its PR targets from 485,000 to 465,000, ...

Attribution (BY): Credit must be given to the creator. Lipidated analogues of glucagon-like peptide 1 (GLP-1) have gained enormous attention as long-acting peptide therapeutics for type 2 diabetes and ...